Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 553 of 5804
-
Can a monthly shot slow stiff heart valves? new trial aims to find out.
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) administered subcutaneously once monthly compared to placebo in slowing the progression of calcific aortic valve stenosis.
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New radioactive drug targets Hard-to-Treat prostate cancer
Disease control Recruiting nowResearchers are looking for a better way to treat participants who have metastatic castration-resistant prostate cancer (mCRPC). mCRPC is a cancer of the prostate (male reproductive gland found below the bladder) that has spread to other parts of the body. This type of prostate …
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Blood test may spare throat cancer patients from radiation side effects
Knowledge-focused Recruiting nowPatients with human papillomavirus (HPV)-related oropharyngeal cancer generally have favorable outcomes and how well they do depends on the specific details about the patient and their cancer. How well they do isn't as related to the kinds of treatment they get. However, there ar…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New malaria pill shows promise in large trial
Disease control CompletedThis study aims to confirm the efficacy, safety and tolerability of KLU156, a fixed dose combination of ganaplacide (KAF156) and a solid dispersion formulation of lumefantrine (lumefantrine-SDF), when administered once daily for three days in adults and children ≥ 10 kg of body w…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo aims to keep High-Risk nasopharyngeal cancer at bay
Disease control Recruiting nowN3 classification, rENE positivity is a high-risk type of locally advanced nasopharyngeal carcinoma. EBV DNA remaining at detectable levels after induction chemotherapy is also a characteristic of high-risk nasopharyngeal carcinoma. Based on the available evidence, patients with …
Phase: PHASE3 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a phone call and a patch help smokers quit for good?
Disease control Recruiting nowThe tobacco use burden in Lebanon is exceptionally high: 35% of adults are current cigarette smokers and 39% are current waterpipe smokers. Although the World Health Organization endorses evidence-based interventions for population-level tobacco dependence treatment, recommended …
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug faricimab takes on leading cause of blindness in nearsighted people
Disease control CompletedThis is a Phase III, multicenter, randomized, double-masked, active comparator-controlled study evaluating the efficacy and safety of faricimab in patients with myopic choroidal neovascularization (CNV). This non-inferiority study will compare 6.0 mg faricimab versus 0.5 mg ranib…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Heart scan software aims to outsmart traditional risk calculators
Prevention Recruiting nowTRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the hypothesis that a Cleerly Coron…
Phase: NA • Sponsor: Cleerly, Inc. • Aim: Prevention
Last updated Jul 12, 2026 00:00 UTC
-
New hope for tough prostate cancer: targeted radiation drug enters phase 2 trial
Disease control OngoingThis is an open-label, randomized, multicenter study of FPI-2265 (225Ac-PSMA-I\&T). Patient population is adult participants with PSMA positive mCRPC who have had previous treatment with with 177Lu-PSMA-617 or another 177Lu-PSMA radioconjugate (RC). The purpose of the study is to…
Phase: PHASE2 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New pill TAK-279 aims to tame Crohn's Flare-Ups
Disease control Recruiting nowCrohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main …
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a vaccine before liver transplant cut antiviral use?
⭐️ VACCINE ⭐️ Recruiting nowThis is a multi-center clinical trial in Cytomegalovirus (CMV) seronegative prospective liver transplant recipients to determine the efficacy of two doses of Cytomegalovirus-Modified Vaccinia Ankara (CMV-MVA) Triplex CMV vaccine pre-transplant. The primary objective is to assess …
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 26, 2026 00:00 UTC
-
Video link to neonatologist may cut newborn deaths in rural hospitals
Disease control Recruiting nowThe purpose of this study is to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed teleneonatology) on the early health outcomes of at-risk neonates delivered in community hospitals.
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Stem cells show promise for failing livers
Disease control CompletedStem cells are non-terminal cells that can self renew and replicate through symmetric or asymmetric division, with the potential to differentiate into different types of cells and tissues. Multiple studies have shown that mesenchymal stem cell has good safety and effectiveness in…
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug could free diabetics from insulin after cell transplant
Disease control Recruiting nowTegoprubart (AT-1501) is a monoclonal antibody. Antibodies are Y-shaped proteins that are produced naturally by the subject's immune system to attack and fight foreign substances that cause illness. Monoclonal antibodies are man-made proteins manufactured to serve as substitute a…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New cell therapy aims to tame deadly transplant complication
Disease control OngoingThis study is a prospective randomized placebo-controlled phase 2 study to compare CYP-001 plus corticosteroids (CS) to placebo plus CS in allogeneic hematologic stem cell transplant recipients with HR-aGvHD. Severity of GvHD will be assessed at screening and throughout the study…
Phase: PHASE2 • Sponsor: Cynata Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Scientists probe nerve signals to give prosthetics a sense of touch
Knowledge-focused Recruiting nowThe goal of this experimental study is to investigate the somatosensory system through intraneural recording and stimulation of the median nerve in healthy volunteers and participants with upper-limb amputation. The main questions it aims to answer are: * How does median nerve a…
Phase: NA • Sponsor: Azienda Ospedaliero, Universitaria Pisana • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New trial aims to find best treatment order for rare lymphoma
Disease control Recruiting nowExtranodal NK/T-cell lymphoma, nasal type (NKTCL) is a common malignant tumor in East Asian populations, often starting in the nasal cavity and spreading to other organs. Associated with EBV infection, NKTCL is aggressive. Early-stage patients typically receive chemo and radiothe…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Cord blood stem cells aim to repair damaged hearts
Disease control Recruiting nowThis is a Phase IIA, randomized, double blind, placebo controlled, multicenter study designed to assess the safety, feasibility, and efficacy of umbilical cord derived mesenchymal stromal cells (UC MSCs, stem cells), administered intravenously (IV) as a single dose or repeated do…
Phase: PHASE2 • Sponsor: Roberto Bolli • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New scans and blood tests aim to catch pancreatic cancer early without surgery
Diagnosis Recruiting nowThe purpose of this study is for researchers to find ways of detecting pancreatic ductal adenocarcinoma/PDAC early to avoid the invasive procedure of surgery. The study researchers think a combination of imaging and a series of blood tests may be an effective way to detect PDAC e…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
New hope for Hard-to-Treat breast cancer: drug trial targets advanced TNBC
Disease control Recruiting nowThis is a Phase II, open-label, single-arm, study, designed to evaluate the efficacy and safety of tenalisib in patients with metastatic TNBC, who have received at least one but not more than 3 prior therapies in a metastatic setting.
Phase: PHASE2 • Sponsor: Rhizen Pharmaceuticals SA • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC